Successful Erlotinib Treatment for a Patient with Gefitinib-Related Hepatotoxicity and Lung Adenocarcinoma Refractory to Intermittently Administered Gefitinib

A 73-year-old Japanese man was histologically diagnosed with lung adenocarcinoma harboring an exon 19 deletion in the epidermal growth factor receptor. The patient was treated with gefitinib for 6 weeks until he developed substantially elevated hepatic enzyme levels that resulted in the discontinuat...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Nagano, Tatsuya, Kotani, Yoshikazu, Kobayashi, Kazuyuki, Katsurada, Masahiro, Hatakeyama, Yukihisa, Hori, Suya, Tamura, Daisuke, Kasai, Daisuke, Funada, Yasuhiro, Nishimura, Yoshihiro
Format: Artigo
Jezik:Inglês
Izdano: Hindawi Publishing Corporation 2011
Teme:
Case Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3420486/
https://ncbi.nlm.nih.gov/pubmed/22937431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/812972
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items